NCI-COG Pediatric MATCH (Molecular Analysis For Therapy Choice)- Phase 2 Subprotocol of Ly3023414 in Patients With Solid Tumors
Phase of Trial: Phase II
Latest Information Update: 30 Nov 2019
Price : $35 *
At a glance
- Drugs Samotolisib (Primary)
- Indications Bone metastases; CNS cancer; Non-Hodgkin's lymphoma; Solid tumours
- Focus Therapeutic Use
- Acronyms Pediatric MATCH
- 31 Aug 2018 Biomarkers information updated
- 09 Apr 2018 Planned End Date changed from 31 Dec 2021 to 30 Sep 2024.
- 09 Apr 2018 Planned primary completion date changed from 31 Dec 2021 to 30 Sep 2024.